OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Allergy and Clinical Immunology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)

Article	Citations
Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker	46
Association between silicosis and autoimmune disease	32
Gene therapy for inborn error of immunity – current status and future perspectives	27
The risk of anaphylaxis on holidays	26
Basophil activation test in food allergy: is it ready for real-time?	26
Chronic urticaria: not only after COVID-19 vaccination	24
Beyond the appearances: exploring complexities in anaphylaxis differential diagnosis	23
Anaphylaxis: glimpse into the future, attention to the present	21
Optimal use of intranasal corticosteroids and intranasal saline, is there a clear answer?	18
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	18
Coronavirus disease 2019 and severe asthma	17
New evidence in food allergies treatment	17
Biologicals in IgE-mediated food allergy	16
The development of the DEFASE project	15
Updates in school-based asthma management	13
Biologicals for the prevention of anaphylaxis	12
Food-labeling issues for severe food-allergic consumers	12
Classifying cephalosporins: from generation to cross-reactivity	12
Emerging developments in the forefront of peanut oral immunotherapy	11
Epidemiology of anaphylaxis	11
Editorial introductions	10
Occupational causes of chronic obstructive pulmonary disease: an update	10
New molecules for atopic dermatitis treatment beyond biological therapy	10
MicroCrystalline Tyrosine-adsorbed immunotherapy	9
Atopic dermatitis endotypes: knowledge for personalized medicine	9

Health disparities in allergic diseases	9
Antibody therapy for COVID-19	9
Endotypes of occupational asthma	9
Psychosocial impact of ocular surface allergic inflammatory disorders	8
Transgenic murine models for the study of drug hypersensitivity reactions linked to HLA-I molecules	8
Management and treatment of perioperative hypersensitivity	8
The role of type 2 diabetes in the severity of adult asthma	8
SARS-CoV-2 vaccination in primary antibody deficiencies: an overview on efficacy, immunogenicity, durability of immune response and safety	8
Editorial: Advances in drug hypersensitivity reactions	8
The use of environmental exposure chambers in studies related to ocular surface effects	8
Clinical outcomes of AIT in the elderly population	8
Role of biologics in severe food allergy	8
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	8
Imaging of chronic rhinosinusitis with nasal polyps in the era of biological therapies	8
Clinical remission in severe asthma: lights and shadows on an ambitious goal	8
The biological basis for current treatment strategies for granulomatous disease in common variable immunodeficiency	8
The pathogenetic role of Th17 immune response in atopic dermatitis	8
Ocular surface itch and pain: key differences and similarities between the two sensations	7
Personalized management for unmet needs with food allergy	7
What molecular allergy teaches us about genetics and epidemiology of allergies	7
Evaluating the glucagon-like peptide-1 receptor in managing asthma	7
Advances in gene therapy for inborn errors of immunity	7
Exploring the management of recurrent angioedema caused by different mechanisms	7
Hymenoptera venom allergy in children and adolescents	6
Biomarkers in the diagnosis of mast cell activation	6
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	6
Highlights of the treatment of allergic rhinitis according to Chinese guidelines	6
Grading the severity of anaphylaxis	6
Liver disease in primary antibody deficiencies	6
Editorial introductions	6
Editorial introductions	6
Where AIRE we now? Where AIRE we going?	6
Regulatory T-cells in asthma	6
Evidence-based management of eczema: five things that should be done more and five things that should be dropped	6
An update on patient reported outcomes in type 2 inflammation airway disease	5
The complexity in DNA methylation analysis of allergic diseases	5
Updates on treatment options in aspirin exacerbated respiratory disease	5
Role of type-2 innate lymphoid cells (ILC2s) in type-2 asthma	5
Long-term outcome of occupational asthma with different etiology	5
Consequences of severe asthma exacerbations	5
Dietary strategies for the prevention of asthma in children	5
Editorial: Pharmacotherapy and evidence based medicine	5
Editorial introductions	5
Update on the use of allergen challenge chambers in immunotherapy: clinical implications	5
Neurostimulation for dry eye disease	5
Inborn errors of immunity underlying defective T-cell memory	5
The impact of obesity on immune function in pediatric asthma	5
Understanding the heterogeneity of childhood allergic sensitization and its relationship with asthma	5
Anaphylaxis: unraveling the mysteries and new perspectives	5
Perspectives in the validation of DEFASE: a paradigm shift in food allergy management	5

Is immunotherapy safe for treatment of severe asthma	4
Economic burden of drug-induced anaphylaxis: what can we do better?	4
Editorial introductions	4
Editorial introductions	4
Global burden of pediatric asthma and rhinitis – what we have recently learned from epidemiology	4
Air pollution and childhood asthma	4
Wood dust and asthma	4
How E-cigarettes and vaping can affect asthma in children and adolescents	4
Role of the ocular surface microbiome in allergic eye diseases	4
Regular consumption following early introduction of allergenic foods and aggressive treatment of eczema are necessary for preventing the development of food allergy in children	4
E-cigarettes and asthma in adolescents	4
Perspectives in precautionary allergen labelling of prepackaged foods after the FAO/WHO consultation	4
Endotypic heterogeneity and pathogenesis in chronic rhinosinusitis	4
Diagnostic criteria of chronic conjunctivitis: atopic keratoconjunctivitis and vernal keratoconjunctivitis	4
Cow's milk allergy	4
Social determinants of health and asthma	4
Pulmonary function testing for the diagnosis of asthma in preschool children	4
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	4
Clinical outcomes of efficacy in food allergen immunotherapy trials	4
Anaphylaxis due to antiallergic and antiasthmatic biologics	4
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	4